Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

Sustained imatinib treatment in chronic myeloid leukemia patients can result in complete molecular response allowing discontinuation without relapse. We set out to evaluate the frequency of complete molecular response in imatinib de novo chronic phase chronic myeloid leukemia patients, to identify b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Etienne, Gabriel, Dulucq, Stéphanie, Nicolini, Franck-Emmanuel, Morisset, Stéphane, Fort, Marie-Pierre, Schmitt, Anna, Etienne, Madeleine, Hayette, Sandrine, Lippert, Eric, Bureau, Caroline, Tigaud, Isabelle, Adiko, Didier, Marit, Gérald, Reiffers, Josy, Mahon, François-Xavier
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943308/
https://ncbi.nlm.nih.gov/pubmed/24362549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.095158
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados